Please Wait.....

Report

APAC Radiopharmaceuticals Market

Market Report I 2024-08-01 I 256 Pages I Data Bridge Market Research

Asia-Pacific radiopharmaceuticals market is expected to reach USD 2.73 billion by 2031 from USD 1.76 billion in 2023, growing at a CAGR of 5.7% in the forecast period of 2024 to 2031.
Market Segmentation:
Asia-Pacific Radiopharmaceuticals Market Segmentation, By Type (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals), Application (Diagnostic and Therapeutic), Drug Type (Generics and Branded), Source (Nuclear reactors, Cyclotrons, and others), End User (Hospitals, Diagnostic Centers, Cancer research institutes, Ambulatory surgical centers, and Others), Countries (China, Japan, Australia, South Korea, Singapore, India, Indonesia, Philippines, Malaysia, Vietnam, and rest of Asia-Pacific)- Industry Trends and Forecast to 2031

Overview of Asia-Pacific Radiopharmaceuticals Market Dynamics:

Driver

- The growing demand for radiopharmceutical among diagnostics and clinical use
Restraint

- Stringent regulations for radiopharmecuticals

Opportunity

- The rising research and development expenditure of radiopharmaceuticals
Market Players:

The key market players operating in the Asia-Pacific radiopharmaceuticals market are listed below:

- Cardinal Health
- Lantheus
- Curium
- GE HealthCare

1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 OVERVIEW OF THE ASIA PACIFIC RADIOPHARMACEUTICALS MARKET 26
1.4 LIMITATIONS 27
1.5 MARKETS COVERED 28
2 MARKET SEGMENTATION 30
2.1 MARKETS COVERED 30
2.2 GEOGRAPHICAL SCOPE 31
2.3 YEARS CONSIDERED FOR THE STUDY 31
2.4 CURRENCY AND PRICING 31
2.5 DBMR TRIPOD DATA VALIDATION MODEL 32
2.6 MULTIVARIATE MODELLING 35
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.8 DBMR MARKET POSITION GRID 37
2.9 MARKET TESTING TYPE COVERAGE GRID 39
2.10 VENDOR SHARE ANALYSIS 40
2.11 SECONDARY SOURCES 41
2.12 ASSUMPTIONS 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 47
4.1 PESTAL ANALYSIS 48
4.2 PORTER FIVE FORCES 49
5 REGULATORY SCENARIO 50
6 MARKET OVERVIEW 52
6.1 DRIVERS 54
6.1.1 THE GROWING DEMAND FOR RADIOPHARMACEUTICALS IN DIAGNOSTICS AND CLINICAL USE 54
6.1.2 THE INCREASING NEED FOR PHARMACEUTICAL PRODUCTS ACROSS VARIED THERAPEUTIC AREAS 54
6.1.3 THE INCREASING PREVALENCE OF CHRONIC DISEASES 55
6.2 RESTRAINTS 55
6.2.1 STRINGENT REGULATIONS FOR RADIOPHARMACEUTICALS 55
6.2.2 POTENTIAL RISKS ASSOCIATED WITH RADIOPHARMACEUTICALS 56
?
6.3 OPPORTUNITIES 57
6.3.1 THE RISING RESEARCH AND DEVELOPMENT EXPENDITURE OF RADIOPHARMACEUTICALS 57
6.3.2 THE GROWING INCIDENCES OF COMPLEX DISEASES IN GERIATRIC POPULATION 57
6.4 CHALLENGES 59
6.4.1 HIGH COST OF DEVELOPMENT AND IMPLEMENTATION OF RADIOPHARMACEUTICALS 59
6.4.2 LACK OF TECHNICAL EXPERTISE AND HIGH COST FOR TRAINING EXISTING WORKFORCE 59
7 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE 60
7.1 OVERVIEW 61
7.2 BRANDED 64
7.3 GENERICS 64
8 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY TYPE 65
8.1 OVERVIEW 66
8.2 DIAGNOSTIC RADIOPHARMACEUTICALS 69
8.2.1 PET RADIOPHARMACEUTICALS 70
8.2.1.1 F-18 70
8.2.1.2 RU-82 70
8.2.1.3 OTHER PET ISOTOPES RADIOPHARMACEUTICALS 70
8.2.2 SPECT RADIOPHARMACEUTICALS 71
8.2.2.1 TECHNETIUM-99M 71
8.2.2.2 GALLIUM-67 71
8.2.2.3 IODINE-123 72
8.2.2.4 THALLIUM-201 72
8.2.2.5 OTHER SPECT ISOTOPES 72
8.3 THERAPEUTIC RADIOPHARMACEUTICALS 72
8.3.1 BRACHYTHERAPY ISOTOPES 72
8.3.1.1 IODINE-125 73
8.3.1.2 PALLADIUM-103 73
8.3.1.3 CESIUM-131 73
8.3.1.4 IRIDIUM-192 73
8.3.1.5 OTHER BRACHYTHERAPY ISOTOPES 73
8.3.2 BETA EMITTERS 74
8.3.2.1 IODINE-131 75
8.3.2.2 LUTHETIUM-177 75
8.3.2.3 SAMARIUM-153 75
8.3.2.4 YTTRIUM-90 75
8.3.2.5 RHENIUM-186 75
8.3.2.6 OTHER BETA EMITTERS 75
?
8.3.3 ALPHA EMITTERS 75
8.3.3.1 RA-223 76
8.3.3.2 OTHERS 76
9 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY APPLICATION 77
9.1 OVERVIEW 78
9.2 DIAGNOSTIC 81
9.2.1 ONCOLOGY 81
9.2.2 CARDIOLOGY 81
9.2.3 NEUROLOGY 81
9.2.4 BONE SCANS 81
9.2.5 THYROID APPLICATIONS 81
9.2.6 PULMONARY SCANS 81
9.2.7 OTHERS 81
9.3 THERAPEUTIC 82
9.3.1 THYROID INDICATIONS 82
9.3.2 BONE METASTASIS 82
9.3.3 LYMPHOMA 82
9.3.4 ENDOCRINE TUMORS 82
9.3.5 OTHER INDICATIONS 82
10 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY SOURCE 83
10.1 OVERVIEW 84
10.2 NUCLEAR REACTORS 87
10.3 CYCLOTRONS 87
10.4 OTHERS 87
11 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY END USER 88
11.1 OVERVIEW 89
11.2 HOSPITALS 92
11.2.1 PUBLIC 92
11.2.2 PRIVATE 92
11.2.2.1 DIAGNOSTIC CENTERS 92
11.2.2.2 CANCER RESEARCH INSTITUTES 92
11.2.2.3 AMBULATORY SURGICAL CENTERS 93
11.2.2.4 OTHERS 93
12 APAC RADIOPHARMACEUTICALS MARKET, BY COUNTRY 94
12.1 ASIA-PACIFIC 94
?
13 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: COMPANY LANDSCAPE 185
13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 185
14 SWOT ANALYSIS 186
15 COMPANY PROFILE 187
15.1 CARDINAL HEALTH 187
15.1.1 COMPANY SNAPSHOT 187
15.1.2 REVENUE ANALYSIS 187
15.1.3 PRODUCT PORTFOLIO 188
15.1.4 RECENT DEVELOPMENT 190
15.2 ADVANCED ACCELERATOR APPLICATIONS, A NOVARTIS COMPANY 191
15.2.1 COMPANY SNAPSHOT 191
15.2.2 REVENUE ANALYSIS 191
15.2.3 PRODUCT PORTFOLIO 192
15.2.4 RECENT DEVELOPMENT 192
15.3 LANTHEUS 193
15.3.1 COMPANY SNAPSHOT 193
15.3.2 REVENUE ANALYSIS 193
15.3.3 PRODUCT PORTFOLIO 194
15.3.4 RECENT DEVELOPMENT 195
15.4 CURIUM 197
15.4.1 COMPANY SNAPSHOT 197
15.4.2 PRODUCT PORTFOLIO 197
15.4.3 RECENT DEVELOPMENT 199
15.5 GE HEALTHCARE 200
15.5.1 COMPANY SNAPSHOT 200
15.5.2 REVENUE ANALYSIS 200
15.5.3 PRODUCT PORTFOLIO 201
15.5.4 RECENT DEVELOPMENT 203
15.6 ANSTO 204
15.6.1 COMPANY SNAPSHOT 204
15.6.2 PRODUCT PORTFOLIO 204
15.6.3 RECENT UPDATES 205
15.7 BAYER AG 207
15.7.1 COMPANY SNAPSHOT 207
15.7.2 REVENUE ANALYSIS 207
15.7.3 PRODUCT PORTFOLIO 208
15.7.4 RECENT DEVELOPMENT 208
?
15.8 BRACCO 210
15.8.1 COMPANY SNAPSHOT 210
15.8.2 PRODUCT PORTFOLIO 210
15.8.3 RECENT DEVELOPMENT 211
15.9 BWX TECHNOLOGIES. INC. 212
15.9.1 COMPANY SNAPSHOT 212
15.9.2 REVENUE ANALYSIS 212
15.9.3 PRODUCT PORTFOLIO 213
15.9.4 RECENT DEVELOPMENT 214
15.10 CHINA ISOTOPE & RADIATION CORPORATION 215
15.10.1 COMPANY SNAPSHOT 215
15.10.2 REVENUE ANALYSIS 215
15.10.3 PRODUCT PORTFOLIO 216
15.10.4 RECENT DEVELOPMENT 217
15.11 ELI LILLY AND COMPANY 218
15.11.1 COMPANY SNAPSHOT 218
15.11.2 REVENUE ANALYSIS 218
15.11.3 PRODUCT PORTFOLIO 219
15.11.4 RECENT DEVELOPMENT 219
15.12 ECKERT & ZIEGLER 220
15.12.1 COMPANY SNAPSHOT 220
15.12.2 REVENUE ANALYSIS 220
15.12.3 PRODUCT PORTFOLIO 221
15.12.4 RECENT DEVELOPMENT 222
15.13 GLOBAL MEDICAL SOLUTIONS 223
15.13.1 COMPANY SNAPSHOT 223
15.13.2 PRODUCT PORTFOLIO 223
15.13.3 RECENT DEVELOPMENT 225
15.14 ECZACIBASI-MONROL 226
15.14.1 COMPANY SNAPSHOT 226
15.14.2 PRODUCT PORTFOLIO 226
15.14.3 RECENT DEVELOPMENT 231
15.15 IBA WORLDWIDE 232
15.15.1 COMPANY SNAPSHOT 232
15.15.2 REVENUE ANALYSIS 232
15.15.3 PRODUCT PORTFOLIO 233
15.15.4 RECENT DEVELOPMENT 234
?
15.16 ISOTOPE JSC 235
15.16.1 COMPANY SNAPSHOT 235
15.16.2 PRODUCT PORTFOLIO 235
15.16.3 RECENT DEVELOPMENT 237
15.17 JUBILANT RADIOPHARMA A JUBILANT PHARMOVA COMPANY 238
15.17.1 COMPANY SNAPSHOT 238
15.17.2 REVENUE ANALYSIS 238
15.17.3 PRODUCT PORTFOLIO 239
15.17.4 RECENT DEVELOPMENT 242
15.18 MALLINCKRODT PHARMACEUTICALS 243
15.18.1 COMPANY SNAPSHOT 243
15.18.2 REVENUE ANALYSIS 243
15.18.3 PRODUCT PORTFOLIO 244
15.18.4 RECENT UPDATES 244
15.19 NTP 245
15.19.1 COMPANY SNAPSHOT 245
15.19.2 PRODUCT PORTFOLIO 245
15.19.3 RECENT DEVELOPMENT 248
15.20 SIEMENS HEALTHCARE GMBH 249
15.20.1 COMPANY SNAPSHOT 249
15.20.2 REVENUE ANALYSIS 249
15.20.3 PRODUCT PORTFOLIO 250
15.20.4 RECENT DEVELOPMENT 251
15.21 STERIGENICS U.S., LLC - A SOTERA HEALTH COMPANY 252
15.21.1 COMPANY SNAPSHOT 252
15.21.2 PRODUCT PORTFOLIO 252
15.21.3 RECENT DEVELOPMENTS 252
16 QUESTIONNAIRE 253
17 RELATED REPORTS 256

Not Sure / Need Reassuring
- Confirm Content
  - Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
    
    Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
    
    Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
    
    Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
- Sample Pages
  - With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
    
    It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
    
    To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Check for Alternatives
  - Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
    
    To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
Prices / Formats / Delivery
- Prices
  - All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
    
    Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Discounts
  - As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
    
    Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
    
    To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Available Currencies
  - Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
    
    Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
    
    To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
- Licenses
  - License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Global Site License
  - The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
    
    It is important to note that this may exclude Parent Companies or Subsidiaries.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Formats
  - The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
    
    If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
- Delivery
  - Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
    
    Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
    
    If a delay in delivery is expected you will be informed about it immediately.
- Shipping Charges
  - As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
    
    If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
Ordering
- By Credit Card
  - We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
    
    Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
    
    For more information on PayU please visit: https://www.payu.pl/en/about-us
- By Money Transfer
  - If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
    
    With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
Security
- Website security
  - We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
    
    Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
- Credit Card Security
  - We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
    
    PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.